Glomerular cross-talk between podocytes and parietal epithelial cells: the role of platelet-derived growth factors (PDGFs)
Glomerular cross-talk between podocytes and parietal epithelial cells: the role of platelet-derived growth factors (PDGFs)
批准号:
210828308
负责人:
Professor Dr. Peter Boor, Ph.D.
金额:
$0.0万
依托单位:
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2012
资助国家:
德国
项目状态:
已结题
起止时间:
2011-12-31 至 2015-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Glomerulosclerosis (FSGS) is the end-point of all progressive glomerular diseases. The nephrologicalemergency, crescentic glomerulonephritis (GN), frequently leads to FSGS. This disease ischaracterized by the formation of glomerular extracapillary cellular proliferates. Apart from lupus andvasculitides, crescents can occur in many GNs and, when present, indicate a severe disease course.In prior studies we have shown that a) the cells lining the inner circumference of the glomerularBowman’s capsule, i.e. parietal epithelial cells (PECs), are crucially involved in both FSGS andcrescent formation; b) that platelet-derived growth factor (PDGF)-DD overexpression in podocytes inmice leads to crescentic and mesangioproliferative GN; c) that PDGFs are potent mitogens andprofibrotic factors for glomerular cells; d) that in glomeruli PDGF receptor-bearing cells mainly includemesangial cells and PECs. Here, we hypothesize, that PDGFs are important mitogens and profibroticactivators of PECs, thereby mediating both crescentic GN and FSGS. To address this hypothesis, wewill use our own unique tools including PDGF-DD deficient mice, PDGF-DD neutralizing antibody, andPEC reporter mice. These will be employed in models of crescentic GN and FSGS. Primary murinePECs will be used in in vitro experiments.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1681/asn.2013040376
发表时间:
2014
期刊:
Journal of the American Society of Nephrology : JASN
影响因子:
--
作者:
[Kevin A. Schulte;Katja Berger;P. Boor;Peggy Jirak;I. Gelman;K. Arkill;C. Neal;W. Kriz;J. Floege;B. Smeets;M. Moeller]
通讯作者:
Kevin A. Schulte;Katja Berger;P. Boor;Peggy Jirak;I. Gelman;K. Arkill;C. Neal;W. Kriz;J. Floege;B. Smeets;M. Moeller
Translational Nephropathology
-
批准号:454024652
-
项目类别:Heisenberg Grants
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:Professor Dr. Peter Boor, Ph.D.
-
依托单位:
Role of epithelial CD74 in renal diseases
-
批准号:432698239
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Professor Dr. Peter Boor, Ph.D.
-
依托单位:
Translational Nephropathology
-
批准号:329501625
-
项目类别:Heisenberg Fellowships
-
资助金额:$0.0万
-
财政年份:2017
-
负责人:Professor Dr. Peter Boor, Ph.D.
-
依托单位:
Translationale Nephropathologie
-
批准号:388978824
-
项目类别:Heisenberg Professorships
-
资助金额:$0.0万
-
财政年份:2017
-
负责人:Professor Dr. Peter Boor, Ph.D.
-
依托单位:
Kidney Keratins, endogenous cytoprotective factors?
-
批准号:318056912
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:Professor Dr. Peter Boor, Ph.D.
-
依托单位:
Role of platelet-derived growth factor (PDGF)-DD in renal fibrosis
-
批准号:201173891
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:Professor Dr. Peter Boor, Ph.D.
-
依托单位:
Coordination Funds
-
批准号:459600179
-
项目类别:Clinical Research Units
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Professor Dr. Peter Boor, Ph.D.
-
依托单位:
Deep learning and pathomics augmented nephropathology
-
批准号:459599325
-
项目类别:Clinical Research Units
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Professor Dr. Peter Boor, Ph.D.
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于NLRP3炎性小体与自噬Cross-talk探讨心康冲剂干预心肌纤维化的机制研究
-
批准号:2025JJ80174
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:邹菊英
-
依托单位:
PKM2琥珀酰化修饰介导癌细胞与血小板间Cross-talk调控胆管癌侵袭转移的研究
-
批准号:JCZRYB202500379
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
基于破骨-成骨细胞Cross-Talk探讨内固定物存留对关节软骨退变的影响及补肾强骨治法的科学内涵
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位:
三痹汤激活线粒体自噬影响免疫细胞Cross talk延缓椎间盘退变的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:王楠
-
依托单位:
多环芳烃(PAHs )介导的癌细胞和Th17细胞“cross-talk”所
致免疫抑制反应在胶质瘤增殖侵袭中的作用及毒理学机制研
究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位:
PGK1乙酰化修饰介导癌细胞与TAMs间Cross-talk调控胆囊癌EMT的研究
-
批准号:82373032
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:王剑明
-
依托单位:
生长激素受体通过脂肪酸介导的肝脏-脂肪Cross-talk影响脂质内稳态的研究
-
批准号:82370866
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:吴英杰
-
依托单位:
线粒体ClpP激动剂通过铁死亡-免疫调控cross-talk治疗急性髓细胞白血病的机制研究
-
批准号:82370171
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:吴俣
-
依托单位:
精氨酸甲基化和泛素化修饰Cross-talk调控METTL3蛋白稳定性促进胰腺癌吉西他滨耐药的机制研究
-
批准号:82303595
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:林承杰
-
依托单位:
Podoplanin/CD177介导供体肺泡巨噬细胞与受体中性粒细胞cross-talk参与肺移植移植物失功的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:温宗梅
-
依托单位: